StocksFundsScreenerSectorsWatchlists
A

A - Agilent Technologies, Inc. Stock Price, Fair Value and News

140.22USD-0.51 (-0.36%)Market Closed

Market Summary

A
USD140.22-0.51
Market Closed
-0.36%

A Alerts

  • 4 major insider sales recently.

A Stock Price

View Fullscreen

A RSI Chart

A Valuation

Market Cap

41.1B

Price/Earnings (Trailing)

33.25

Price/Sales (Trailing)

6.1

EV/EBITDA

24.79

Price/Free Cashflow

24.92

A Price/Sales (Trailing)

A Profitability

Operating Margin

67.57%

EBT Margin

19.78%

Return on Equity

19.97%

Return on Assets

11.29%

Free Cashflow Yield

4.01%

A Fundamentals

A Revenue

Revenue (TTM)

6.7B

Rev. Growth (Yr)

-5.58%

Rev. Growth (Qtr)

-1.78%

A Earnings

Earnings (TTM)

1.2B

Earnings Growth (Yr)

-1.14%

Earnings Growth (Qtr)

-26.74%

Breaking Down A Revenue

Last 7 days

-2.9%

Last 30 days

-4.9%

Last 90 days

7.4%

Trailing 12 Months

0.7%

How does A drawdown profile look like?

A Financial Health

Current Ratio

2.68

Debt/Equity

0.41

Debt/Cashflow

0.77

A Investor Care

Dividend Yield

0.65%

Dividend/Share (TTM)

0.91

Buy Backs (1Y)

0.90%

Diluted EPS (TTM)

4.18

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20246.7B000
20236.9B7.0B7.0B6.8B
20226.4B6.5B6.7B6.8B
20215.5B5.8B6.1B6.3B
20205.2B5.2B5.2B5.3B
20195.0B5.0B5.1B5.2B
20184.6B4.7B4.8B4.9B
20174.2B4.3B4.4B4.5B
20164.0B4.1B4.1B4.2B
20154.1B4.0B4.0B4.0B
20143.9B4.0B4.0B4.0B
20136.9B6.9B6.8B3.9B
20126.7B6.8B6.8B6.9B
20115.8B6.2B6.5B6.6B
20104.5B4.7B5.0B5.4B
20095.5B5.1B4.8B4.5B
2008005.6B5.8B
20070005.4B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Agilent Technologies, Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 25, 2024
binns philip
sold
-417,096
147
-2,827
senior vice president
Mar 15, 2024
fields heidi
acquired
247,471
147
1,678
-
Mar 15, 2024
bishop hans edgar
acquired
358,081
147
2,428
-
Mar 15, 2024
anand mala
acquired
247,471
147
1,678
-
Mar 15, 2024
rataj sue h.
acquired
247,471
147
1,678
-
Mar 15, 2024
wilson dow r
acquired
247,471
147
1,678
-
Mar 15, 2024
scangos george a
acquired
247,471
147
1,678
-
Mar 15, 2024
koh boon hwee
acquired
247,471
147
1,678
-
Mar 15, 2024
brawley otis w
acquired
358,081
147
2,428
-
Mar 15, 2024
koh boon hwee
sold (taxes)
-74,329
147
-504
-

1–10 of 50

Which funds bought or sold A recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 12, 2024
First PREMIER Bank
new
-
1,000
1,000
-%
Apr 12, 2024
Exchange Bank
reduced
-0.57
21,798
558,176
0.46%
Apr 12, 2024
Global Trust Asset Management, LLC
unchanged
-
8,113
182,179
0.07%
Apr 12, 2024
Pacifica Partners Inc.
unchanged
-
1,580
13,089
0.01%
Apr 12, 2024
FCF Advisors LLC
reduced
-17.9
-267,902
1,636,110
0.41%
Apr 12, 2024
FIRST FINANCIAL CORP /IN/
new
-
7,129
7,129
-%
Apr 12, 2024
Riverview Trust Co
new
-
41,179
41,179
0.03%
Apr 12, 2024
Westend Capital Management, LLC
new
-
3,056
3,056
-%
Apr 12, 2024
Capital Planning LLC
unchanged
-
12,669
295,240
0.10%
Apr 12, 2024
Lloyd Advisory Services, LLC.
added
613
1,324,430
1,529,260
0.33%

1–10 of 48

Are Funds Buying or Selling A?

Are funds buying A calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own A
No. of Funds

Unveiling Agilent Technologies, Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Apr 10, 2024
vanguard group inc
10.20%
29,882,462
SC 13G/A
Feb 13, 2024
vanguard group inc
8.63%
25,277,234
SC 13G/A
Jan 25, 2024
blackrock inc.
9.3%
27,257,254
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
2.6%
7,707,066
SC 13G/A
Feb 09, 2023
vanguard group inc
8.53%
25,250,988
SC 13G/A
Jan 26, 2023
blackrock inc.
10.9%
32,309,878
SC 13G/A
Jan 20, 2023
blackrock inc.
10.9%
32,309,878
SC 13G/A
Apr 08, 2022
blackrock inc.
10.0%
30,082,335
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
7.1%
21,689,105
SC 13G/A
Feb 09, 2022
vanguard group inc
8.04%
24,269,735
SC 13G/A

Recent SEC filings of Agilent Technologies, Inc.

View All Filings
Date Filed Form Type Document
Apr 10, 2024
SC 13G/A
Major Ownership Report
Mar 27, 2024
4
Insider Trading
Mar 25, 2024
144
Notice of Insider Sale Intent
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading

Peers (Alternatives to Agilent Technologies, Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
177.3B
23.9B
-3.91% -4.78%
37.37
7.42
-10.33% -33.23%
41.1B
6.7B
-4.92% 0.73%
33.25
6.1
-2.81% -6.58%
40.8B
3.7B
-7.22% 1.87%
48.33
11.16
8.72% 24.44%
14.2B
9.3B
0.30% -9.60%
16.68
1.54
-6.38% -9.73%
12.1B
4.1B
-8.95% 15.76%
25.51
2.93
3.86% -2.39%
11.9B
1.9B
-2.43% 101.48%
42.11
6.31
29.17% 15.26%
11.9B
2.5B
13.24% -2.16%
-58.11
4.75
19.93% 67.26%
10.9B
1.1B
0.99% 75.89%
-25.11
10.08
31.99% 20.63%
MID-CAP
2.6B
929.2M
-20.88% -25.40%
1.7K
2.8
28.93% 111.61%
2.1B
563.9M
-3.78% -30.33%
-4.33
3.68
25.45% 26.76%
SMALL-CAP
425.1M
280.3M
-19.03% -7.55%
-2.23
1.52
-12.89% -148.37%
86.5M
31.2M
4.27% -86.20%
-0.98
2.77
5.03% -1.81%
41.5M
9.2M
-6.67% -36.96%
-2.48
4.53
11.85% 44.12%
6.1M
9.0M
-2.70% -65.71%
-0.85
0.68
-53.31% 2.21%
183.8K
25.9M
-50.00% -94.83%
-0.01
0.01
-57.78% -93.11%

Agilent Technologies, Inc. News

Latest updates
MarketBeat6 hours ago

Agilent Technologies, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-1.8%1,6581,6881,6721,7171,7561,8491,7181,6071,6741,6601,5861,5251,5481,4831,2611,2381,3571,3671,2741,2381,284
Costs and Expenses-0.5%1,2741,2801,5391,3341,3301,3781,3071,2471,2981,2651,2501,2371,2201,1841,0311,1361,1421,1171,0491,0221,034
  S&GA Expenses0.8%396393407415419422412386417389403420407387347358404385366354355
  R&D Expenses12.3%12811411812612311911611511711611310910310292.0019710410210199.00102
EBITDA Margin0.6%0.25*0.25*0.25*0.29*0.29*0.28*0.29*0.28*0.28*0.28*0.26*0.25*---------
Interest Expenses0%22.0022.0024.0024.0025.0023.0019.0021.0021.0021.0021.0020.0019.0019.0019.0020.0020.0021.0018.0017.0018.00
Income Taxes200.0%55.00-55.0021.0075.0058.0087.0068.0059.0036.006.0063.0057.0024.0061.0020.0020.0022.0037.0031.0036.00-256
Earnings Before Taxes-4.0%403420132377410455397333319448327273312283219121219231222218248
EBT Margin0.9%0.20*0.20*0.20*0.23*0.23*0.22*0.22*0.22*0.21*0.22*0.19*0.19*---------
Net Income-26.7%348475111302352368329274283442264216288222199101197194191182504
Net Income Margin1.1%0.18*0.18*0.16*0.19*0.19*0.18*0.20*0.19*0.19*0.19*0.16*0.16*---------
Free Cashflow-8.6%395432481341220378244219180379280441---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets1.7%10,94810,76310,67510,79210,91910,53210,48410,45510,32710,70510,49110,3989,6749,6279,5469,4559,5019,4528,6259,0228,952
  Current Assets3.6%4,3384,1864,0303,9494,0783,7783,6903,6433,4743,7993,6323,5143,4833,4153,2453,1713,1023,1893,4573,8123,712
    Cash Equivalents10.1%1,7501,5901,3291,1751,2501,0531,0731,1881,1161,4841,4351,3871,3361,4471,3641,3291,2321,3881,7712,1612,064
  Inventory0.2%1,0331,0311,0721,1031,1111,0381,010937879830818791755720746750706679660657653
  Net PPE3.5%1,3141,2701,2111,1841,1471,1001,0541,010974945905884866845846836844850839827829
  Goodwill0.2%3,9673,9603,9843,9803,9833,9523,9483,9563,9643,9753,9764,0543,6183,6023,6063,5823,5893,5933,1073,1123,133
Liabilities-3.2%4,7604,9185,1175,0115,3105,2275,3935,3335,1735,3165,5455,5884,8704,7544,5654,6874,6534,7043,8783,8973,916
  Current Liabilities0.9%1,6171,6031,7601,6661,9361,8611,9021,8131,5841,7081,7241,7581,6871,4671,3141,9451,8922,0801,6221,1181,095
  Short Term Borrowings---55.00-23836.00180175--13020531475.0040.00700675616504--
  Long Term Debt-6.6%2,5552,7352,7342,7332,7332,7332,7322,7302,7302,7292,7282,7272,1852,2842,2831,7881,7871,7911,2941,7981,798
    LT Debt, Non Current--------2,7302,7302,7292,7282,7272,1852,2842,2831,7881,7871,7911,2941,7981,798
Shareholder's Equity5.9%6,1885,8455,5585,7815415,3051395,2921595,3895,3074,8104,8044,8733.005,2883.005,2774,7475,1255,036
  Retained Earnings35.7%1,06178244470054132413916015934890.00-12.004.0081.0013015.0073.00-18.00-12217890.00
  Additional Paid-In Capital1.0%5,4405,3875,3825,3605,3455,3255,3115,2925,2905,3205,3075,2715,2665,3115,3245,2885,2935,2775,2705,3435,324
Shares Outstanding0.3%293292293295296295300299301304305305---------
Minority Interest----------------------
Float----31,200---26,600---30,900---18,000---18,900-
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-6.0%485516562398296448326283255441334472238377290313-59.00314242252213
  Share Based Compensation214.3%44.0014.0029.0024.0044.0026.0028.0027.0044.0022.0022.0026.0040.0020.0019.0017.0027.0015.0017.0016.0024.00
Cashflow From Investing-137.5%-95.00-40.00-89.00-77.00-104-110-73.00-76.00-79.00-59.00-61.00-587-42.00-27.00-32.00-53.00-35.00-1,193-51.00-56.00-290
Cashflow From Financing-19.4%-240-201-322-390-17.00-341-362-123-546-324-222166-316-269-231-156-61.00497-582-92.00-122
  Dividend Payments-69.00---67.00----------------
  Buy Backs-100.0%-1183378.0075.0025828824.004471471131733443165.0022.0060.0049.0054950.0075.00

A Income Statement

2024-01-31
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Net revenue:  
Net revenue$ 1,658$ 1,756
Costs and expenses:  
Cost of revenue750788
Research and development128123
Selling, general and administrative396419
Total costs and expenses1,2741,330
Income from operations384426
Interest income189
Interest expense(22)(25)
Other income (expense), net230
Income before taxes403410
Provision for income taxes5558
Net income$ 348$ 352
Net income per share  
Basic$ 1.19$ 1.19
Diluted$ 1.18$ 1.19
Weighted average shares used in computing net income per share:  
Basic293296
Diluted294297
Product  
Net revenue:  
Net revenue$ 1,209$ 1,323
Costs and expenses:  
Cost of revenue514556
Service and Other  
Net revenue:  
Net revenue449433
Costs and expenses:  
Cost of revenue$ 236$ 232

A Balance Sheet

2024-01-31
CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) - USD ($)
$ in Millions
Jan. 31, 2024
Oct. 31, 2023
Current assets:  
Cash and cash equivalents$ 1,748$ 1,590
Accounts receivable, net1,2951,291
Inventory1,0331,031
Other current assets262274
Total current assets4,3384,186
Property, plant and equipment, net1,3141,270
Goodwill3,9673,960
Other intangible assets, net443475
Long-term investments170164
Other assets716708
Total assets10,94810,763
Current liabilities:  
Accounts payable488418
Employee compensation and benefits272371
Deferred revenue522505
Other accrued liabilities335309
Total current liabilities1,6171,603
Long-term debt2,5552,735
Retirement and post-retirement benefits102103
Other long-term liabilities486477
Total liabilities4,7604,918
Commitments and Contingencies (Note 9 and 12)
Stockholders' equity:  
Preferred stock; $0.01 par value; 125,000,000 shares authorized; none issued and outstanding at January 31, 2024 and October 31, 202300
Common stock; $0.01 par value; 2,000,000,000 shares authorized; 293,041,817 shares at January 31, 2024 and 292,123,241 shares at October 31, 2023, issued and outstanding33
Additional paid-in-capital5,4405,387
Retained earnings1,061782
Accumulated other comprehensive loss(316)(327)
Total stockholder's equity6,1885,845
Total liabilities and equity$ 10,948$ 10,763
A
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
0
 WEBSITEagilent.com
 INDUSTRYDiagnostics & Research

Agilent Technologies, Inc. Frequently Asked Questions


What is the ticker symbol for Agilent Technologies, Inc.? What does A stand for in stocks?

A is the stock ticker symbol of Agilent Technologies, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Agilent Technologies, Inc. (A)?

As of Mon Apr 15 2024, market cap of Agilent Technologies, Inc. is 41.09 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of A stock?

You can check A's fair value in chart for subscribers.

What is the fair value of A stock?

You can check A's fair value in chart for subscribers. The fair value of Agilent Technologies, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Agilent Technologies, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for A so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Agilent Technologies, Inc. a good stock to buy?

The fair value guage provides a quick view whether A is over valued or under valued. Whether Agilent Technologies, Inc. is cheap or expensive depends on the assumptions which impact Agilent Technologies, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for A.

What is Agilent Technologies, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 15 2024, A's PE ratio (Price to Earnings) is 33.25 and Price to Sales (PS) ratio is 6.1. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. A PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Agilent Technologies, Inc.'s stock?

In the past 10 years, Agilent Technologies, Inc. has provided 0.143 (multiply by 100 for percentage) rate of return.